The role of endoplasmic reticulum stress in maintaining and targeting multiple myeloma: a double-edged sword of adaptation and apoptosis

White-Gilbertson, Shai; Yunpeng Hua; Bei Liu
May 2013
Frontiers in Genetics;May2013, Vol. 3, preceding p1
Academic Journal
No abstract available.


Related Articles

  • Endoplasmic reticulum stress in the kidney. Kitamura, Masanori // Clinical & Experimental Nephrology;Oct2008, Vol. 12 Issue 5, p317 

    Endoplasmic reticulum (ER) stress is involved in a wide range of pathological circumstances including neurodegenerative disorders, diabetes mellitus, ischemic injury, cancers, atherosclerosis, inflammation, infection, toxicity of chemicals and metals, and psychotic diseases. ER stress is also...

  • Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress. Ullman, E.; Fan, Y.; Stawowczyk, M.; Chen, H.-M.; Yue, Z.; Zong, W.-X. // Cell Death & Differentiation;Feb2008, Vol. 15 Issue 2, p422 

    A letter to the editor is presented concerning the role of autophagy in promoting necrosis in apoptosis-deficient cells in response to endoplasmic reticulum stress.

  • Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells. Auner, Holger W.; Moody, Anne Marie; Ward, Theresa H.; Kraus, Marianne; Milan, Enrico; May, Philippa; Chaidos, Aristeidis; Driessen, Christoph; Cenci, Simone; Dazzi, Francesco; Rahemtulla, Amin; Apperley, Jane F.; Karadimitris, Anastasios; Dillon, Niall // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Inhibition of the proteasome is a widely used strategy for treating multiple myeloma that takes advantage of the heavy secretory load that multiple myeloma cells (MMCs) have to deal with. Resistance of MMCs to proteasome inhibition has been linked to incomplete disruption of proteasomal...

  • Endoplasmic Reticulum Stress in Age-Related Macular Degeneration: Trigger for Neovascularization. Salminen, Antero; Kauppinen, Anu; Hyttinen, Juha M. T.; Toropainen, Elisa; Kaarniranta, Kai // Molecular Medicine;Nov/Dec2010, Vol. 16 Issue 11/12, p535 

    Age-related macular degeneration (AMD) can be classified into two main categories: the atrophic, dry form and the exudative, wet form. The crucial difference between dry and wet AMD is the development of choroidal neovascularization in wet AMD. One fundamental cause of the neovascularization is...

  • Azacytidine induces necrosis of multiple myeloma cells through oxidative stress. Tian, Enbing; Tang, Haiping; Renhua Xu; Chongdong Liu; Haiteng Deng; Qingtao Wang // Proteome Science;2013, Vol. 11 Issue 1, p1 

    Azacytidine is an inhibitor of DNA methyltransferase and is known to be an anti-leukemic agent to induce cancer cell apoptosis. In the present study, multiple myeloma cells were treated with azacytidine at clinically relevant concentrations to induce necrosis through oxidative stress. Necrotic...

  • Synergistic Apoptosis Induction in Leukemic Cells by the Phosphatase Inhibitor Salubrinal and Proteasome Inhibitors. Drexler, Hannes C. A. // PLoS ONE;2009, Vol. 4 Issue 1, p1 

    Background: Cells adapt to endoplasmic reticulum (ER)-stress by arresting global protein synthesis while simultaneously activating specific transcription factors and their downstream targets. These processes are mediated in part by the phosphorylation-dependent inactivation of the translation...

  • Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma. Kelly, K R; Espitia, C M; Mahalingam, D; Oyajobi, B O; Coffey, M; Giles, F J; Carew, J S; Nawrocki, S T // Oncogene;6/21/2012, Vol. 31 Issue 25, p3023 

    Oncolytic virotherapy with reovirus has demonstrated anti-cancer activity and minimal toxicity in clinical trials, but the mechanisms underlying these effects have not been fully elucidated. Reolysin, a proprietary formulation of reovirus for cancer therapy, stimulated selective viral...

  • Targeting the Ubiquitin-Proteasome Pathway in Cancer Therapy. Ishii, Yuki; Waxman, Samuel; Germain, Doris // Anti-Cancer Agents in Medicinal Chemistry;2007, Vol. 7 Issue 3, p359 

    The ubiquitin-proteasome pathway plays a central role in the degradation of proteins involved in several pathways including the cell cycle, cellular proliferation and apoptosis. Bortezomib is the first proteasome inhibitor to enter clinical use, and received approval by the Food and Drug...

  • The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction. Descamps, G; Gomez-Bougie, P; Tamburini, J; Green, A; Bouscary, D; Ma├»ga, S; Moreau, P; Le Gouill, S; Pellat-Deceunynck, C; Amiot, M // British Journal of Cancer;5/8/2012, Vol. 106 Issue 10, p1660 

    Background:Cancer cells are frequently addicted to deregulated oncogenic protein translation. The small molecule 4EG-I selectively inhibits the cap-dependent translation of mRNAs. As multiple myeloma is an incurable disease that requires new therapeutic approaches, we investigated whether...

  • The Apoptotic Pathways and Their Mechanisms. LI Min; IN Jun // Journal of International Obstetrics & Gynecology;Apr2014, Issue 41, p103 

    Ceil apoptosis exists in the whole life of multicellular organisms, which is capable to maintain homeostasis of tissues and organs through removing unwanted or damaged cells. Eukaryotic cells mediate apoptosis through four main pathways:the death receptor-mediated extrinsic pathway, the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics